We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




World’s Smallest Implantable Brain Stimulator Demonstrated in Human Patient

By HospiMedica International staff writers
Posted on 15 Apr 2024
Print article
Image: The first-ever miniaturized brain stimulator has been shown to work in a human patient (Photo courtesy of Rice University)
Image: The first-ever miniaturized brain stimulator has been shown to work in a human patient (Photo courtesy of Rice University)

Implantable devices that deliver electrical stimulation to the central or peripheral nervous system are increasingly employed in the treatment of psychiatric conditions, movement disorders, and pain issues, and for helping to restore mobility after spinal cord injuries. However, the current implantable devices used for brain stimulation depend on comparatively large batteries. These batteries need to be implanted under the skin at a location different from the stimulation device and are connected by long wires. This arrangement requires additional surgeries, increases the risk of hardware complications like wire breakage, and often requires surgeries to replace batteries. Engineers have now developed what is considered the smallest implantable brain stimulator used in a human to date. Utilizing innovative magnetoelectric power transfer technology, this tiny device can be wirelessly powered by an external transmitter and is capable of stimulating the brain through the dura—the protective membrane that lines the base of the skull.

This device, created by engineers at Rice University (Houston, TX, USA) and dubbed the Digitally programmable Over-brain Therapeutic (DOT), could transform the treatment landscape for drug-resistant depression and other psychiatric or neurological disorders. It provides a less invasive alternative compared to existing neurostimulation therapies and other brain-computer interfaces (BCIs), offering greater patient autonomy and easier access. The device utilizes a material that efficiently converts magnetic fields into electrical energy. This conversion is highly efficient even at small dimensions and tolerates alignment errors well, simplifying the activation and control processes. The device itself is 9 millimeters wide and capable of delivering up to 14.5 volts of electrical stimulation.

In initial tests, the device was temporarily implanted in a human patient to stimulate the motor cortex, the brain region that controls movement, successfully eliciting a hand movement. Further tests showed that the device could stably interface with the brain for up to 30 days in pig models. The implant procedure, taking about 30 minutes, involves placing the device within the skull bone, resulting in an almost invisible incision and implant site. Patients would be able to return home on the same day as the procedure. The technology could allow it to be operated comfortably from home. Doctors would prescribe and oversee the treatment, but patients would manage the application themselves.

“In the future, we can place the implant above other parts of the brain, like the prefrontal cortex, where we expect to improve executive functioning in people with depression or other disorders,” said Jacob Robinson, a professor of electrical and computer engineering and of bioengineering at Rice.

Related Links:
Rice University 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Antegrade Femoral Nailing System
AUTOBAHN EVO

Print article

Channels

Critical Care

view channel
Image: The largest scale analysis compared longer-term percutaneous devices for aortic valve replacement versus surgery (Photo courtesy of Adobe Stock)

Transcatheter Valve Replacement Outcomes Similar To Surgery, Finds Study

A new study has shown that a minimally invasive procedure for replacing the aortic valve in the heart—known as transcatheter aortic valve replacement (TAVR)—is on par with the more traditional surgical... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.